How long should Coumadin (warfarin) be held prior to hip replacement surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Warfarin Management Before Hip Replacement Surgery

Warfarin should be stopped 4 to 5 days before hip replacement surgery to allow the INR to return to normal (1.2) at the time of the procedure. 1

Risk Stratification Approach

The management of warfarin before hip replacement surgery depends on the patient's risk of thromboembolism:

Low-Risk Patients

  • Patients with atrial fibrillation without history of stroke 2
  • Patients without venous thromboembolic events for more than 3 months 2
  • Patients with bileaflet mechanical valve in aortic position 2

Management for Low-Risk Patients:

  • Stop warfarin 4-5 days before surgery 1
  • Allow INR to fall to normal or near normal (1.3-1.5) by the time of surgery 1
  • Resume warfarin postoperatively at maintenance dose 1
  • Consider supplementing with low-dose heparin (5000 U) or LMWH subcutaneously every 12 hours if necessary 1

Moderate-Risk Patients

  • Patients with history of venous thromboembolism within 3-6 months 2

Management for Moderate-Risk Patients:

  • Stop warfarin 4-5 days before surgery 1
  • Administer prophylactic doses of heparin (5000 U) or LMWH (3000 U) subcutaneously every 12 hours starting 2 days before procedure 1
  • Restart prophylactic heparin or LMWH 12 hours postoperatively along with warfarin 1
  • Continue combination until INR returns to therapeutic range (4-5 days) 1
  • Delay heparin or LMWH for 24 hours or longer if high risk of postoperative bleeding 1

High-Risk Patients

  • Patients with recent thromboembolic events (within 3 months) 2
  • Patients with mechanical heart valve in mitral position 2
  • Patients with older model cardiac valve (ball/cage) 2

Management for High-Risk Patients:

  • Stop warfarin 4-5 days before surgery with close INR monitoring 1, 2
  • When INR falls below therapeutic range, administer therapeutic doses of heparin (15,000 U every 12 hours subcutaneously) or LMWH (100 U/kg every 12 hours) 1
  • Discontinue heparin 24 hours before surgery or LMWH 12-24 hours before surgery 1, 2
  • For critical anticoagulation needs, consider hospital admission for continuous IV heparin (1300 U/h) stopped 5 hours before surgery 1
  • Restart heparin or LMWH in prophylactic doses 12 hours postoperatively along with warfarin 1
  • Continue until INR reaches therapeutic range 1

Alternative Approaches

For patients who need more rapid reversal of anticoagulation:

  • Administer vitamin K 2.5 mg orally 2 days before procedure to reduce the period off warfarin to 2 days 1
  • For urgent hip fracture surgery, low-dose intravenous vitamin K protocol can safely reverse warfarin within 18 hours 3

Postoperative Management

  • Resume warfarin 12-24 hours after surgery when adequate hemostasis is achieved 4, 5
  • For patients undergoing hip arthroplasty, consider using lower leg compression devices in addition to anticoagulation 6
  • The preferred method of prophylaxis for elective hip replacement is LMWH rather than adjusted-dose warfarin 2

Common Pitfalls and Caveats

  • Failure to account for patient's thromboembolism risk can lead to serious complications 2
  • Insufficient time off warfarin may lead to excessive surgical bleeding 7
  • Overly aggressive reversal in high-risk patients may lead to thromboembolism 1, 2
  • Elderly patients (>75 years) require lower warfarin doses and may have higher bleeding risk 1
  • Patients with renal insufficiency may have prolonged LMWH half-life, requiring dose adjustment 2
  • Inadequate bridging therapy for high-risk patients can lead to thromboembolic events 1, 2

Early administration of vitamin K for hip fracture patients on warfarin is associated with earlier operative management and fewer postoperative complications 7, 3.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.